(Q52606764)

4 May 2018

title

Absence of nucleolar parafibromin immunoreactivity in subsets of parathyroid malignant tumours. (English)

1 reference

4 May 2018

author

Carl C Juhlin

1

1 reference

4 May 2018

author name string

Felix Haglund

2

1 reference

4 May 2018

Takao Obara

3

1 reference

4 May 2018

Andrew Arnold

4

1 reference

4 May 2018

Catharina Larsson

5

1 reference

4 May 2018

Anders Höög

6

1 reference

4 May 2018

publication date

8 January 2011

1 reference

4 May 2018

published in

Virchows Archiv

1 reference

4 May 2018

volume

459

1 reference

4 May 2018

issue

1

1 reference

4 May 2018

page(s)

47-53

1 reference

4 May 2018

https://scigraph.springernature.com/pub.10.1007/s00428-010-1032-3

exact match

0 references

cites work

HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1032-3

HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1032-3

Somatic and Germ-Line Mutations of theHRPT2Gene in Sporadic Parathyroid Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1032-3

Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1032-3

Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1032-3

Defining a molecular phenotype for benign and malignant parathyroid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1032-3

Nucleolar localization of parafibromin is mediated by three nucleolar localization signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1032-3

Defective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism-jaw tumor syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1032-3

Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1032-3

Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1032-3

JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1032-3

Nucleolus, ribosomes, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1032-3

Loss of parafibromin expression in a subset of parathyroid adenomas

21 January 2018

1 reference

12 December 2020

Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias

1 reference

12 December 2020

Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma

1 reference

12 December 2020

Clinical course of metastatic parathyroid cancer

1 reference

12 December 2020

Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification

1 reference

12 December 2020

Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas

1 reference

12 December 2020

10.1007/S00428-010-1032-3

Identifiers

DOI

1 reference

4 May 2018

1 reference

4 May 2018